GLP-1 coverage in New Hampshire
Medicaid no longer covers GLP-1s for obesity here. What that means, the indications that are still mandatory, and what it costs if you pay cash.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
New Hampshire eliminated Medicaid coverage of GLP-1s for obesity treatment.
New Hampshire ended coverage after October 2025 and also appears on KFF’s list of states covering one or more weight-loss drugs while covering no GLP-1s. Both things being true at once is exactly why reading your own plan documents matters more than reading a national summary. Everything below is sourced — we are not going to tell you what a New Hampshire clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.
Why New Hampshire is different
New Hampshire is in the Northeast, the region with adult obesity prevalence of 30.3%, and it is one of the smaller Medicaid programmes to have changed position. Like Pennsylvania it appears on both KFF lists — having eliminated GLP-1 coverage for obesity, and as a state covering a weight-loss drug while covering no GLP-1.
Medicaid and GLP-1s in New Hampshire
Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where New Hampshire sits.
| New Hampshire | |
|---|---|
| Status | Medicaid no longer covers GLP-1s for obesity here |
| Region | Northeast — regional adult obesity prevalence 30.3% |
| Board of pharmacy | New Hampshire Board of Pharmacy |
If you are on Medicaid in New Hampshire
What to do in New Hampshire: Do not rely on a summary that says your state covers weight-loss medication. Get the specific drug name checked against the formulary.
Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.
Paying cash in New Hampshire
Providers are licensed across all 50 states and charge the same here as anywhere, so there is no local price to hunt for — the cheapest verified all-in rates are Ozari Health at $86 for semaglutide and Trimi at $125 for tirzepatide. Full tables in the cheapest tirzepatide. If you buy compounded, check the pharmacy licence with the New Hampshire Board of Pharmacy, or with the board in whichever state that pharmacy actually operates from — frequently not New Hampshire.
New Hampshire: common questions
Why does New Hampshire appear on two different KFF lists?
Because both things are true: it eliminated GLP-1 coverage for obesity after October 2025, and it is among the seven states covering at least one weight-loss drug while covering no GLP-1. A summary saying the state covers weight-loss medication is accurate and useless.
Does this affect diabetes prescriptions?
No. Coverage for type 2 diabetes is required under federal Medicaid rules and is not affected by a state's decision on obesity coverage.
Sources: KFF, “Medicaid Coverage of and Spending on GLP-1s”, 16 January 2026; CDC Adult Obesity Prevalence Maps, 2024 data, published 3 December 2025. Verified 2026-09-18. Coverage positions change mid-year — confirm yours with your plan. Not medical, legal or benefits advice.
More from the desk
- Medicare, GLP-1s and the $50 month
CMS is running a time-limited programme giving eligible Part D members certain GLP-1s for $50 a month. If you are on Medicare, read this before paying cash for anything.
- The cheapest tirzepatide online
Every provider whose monthly price actually includes the medication, sorted on what you are billed in month two.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.